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Background: Mortality from infections has been reported to be higher in hemodialysis 
(HD) patients.  Although dysfunction of neutrophils against bacterial infection was 
reported in HD patients, the precise mechanism remains to be clarified.  We therefore 
examined the impacts of neutrophil inflammatory signaling on bactericidal activity in 
HD patients. 
Methods: Comprehensive analyses of intracellular signalings were performed in whole 
blood of HD patients and control using microarray system.  To confirm the 
contribution of the signaling to bactericidal activity in neutrophils, we examined the 
phosphorylation, bacterial killing function, reactive oxygen species (ROS) production 
and myeloperoxidase (MPO) release in neutrophils against staphylococcus aureus (S. 
aureus).   
Results: RNA microarray analysis showed the suppression of p38 mitogen activated 
protein kinase (MAPK) signaling in HD patients.  Neutrophils in HD patients showed 
the impairment of bactericidal activity against S. aureus compared to healthy subjects.  
Phosphorylation rate of p38MAPK of neutrophils in response to S. aureus was lower in 
HD patients than healthy subjects.  The levels of ROS produced by neutrophils after 
co-culture with S. aureus were lower in HD patients, on the other hand, there was no 
difference of MPO release between HD patients and healthy subjects.  A selective 
pharmacological inhibitor of p38MAPK suppressed bacterial killing function as well as 
ROS production in neutrophils of healthy subjects.  
Conclusions: Impairment of p38MAPK signaling pathway might contribute to the 
suppression of neutrophil bactericidal activity in HD patients through the less 












Infection is the second cause of death following cardiovascular diseases in patients on 
hemodialysis (HD) [1, 2].  Especially, the mortality rate of HD patients due to sepsis 
has been reported to be higher in every age bracket [3].  Numerous risk factors 
predispose HD patients to infection.  Vascular access was a major risk factor for 
infection and bacteremia, and the most common micro-organism was staphylococcus 
aureus (S. aureus) in HD patients [4].  HD patients with S. aureus bacteremia are 
known to be at notable risk for endocarditis, which is a life-threating infectious disease 
[5, 6].  Other potential risk factors for infection include high burden of coexisting 
illnesses, hypoalbuminemia [7, 8], immunosuppressive therapy [9], nephrotic syndrome 
[10], uremia, anemia, malnutrition [11] and change of susceptibility of bacteria to 
antibiotics [12].  However, the precise reasons why HD patients are susceptible to 
bacteremia remain to be clarified. 
 
Host defense systems to protect from infection comprise mechanical barriers such as 
skin, and non-specific (innate)/specific (adaptive) immune systems [13, 14].  
Neutrophils are thought to be responsible for the first-line non-specific defense systems 
against bacterial infection through their anti-bacterial activities [14, 15].  Neutrophils 
migrate to the site of bacterial infection along a chemotactic gradient, ingest the 
invading microorganisms by phagocytosis and kill them with proteolytic enzymes such 
as reactive oxidative species (ROS) and myeloperoxidase (MPO).  All of these 
functions are regulated by various intracellular signaling pathways in neutrophils.  
Previous studies reported impairments of neutrophil antibacterial activities such as 
migration, bactericidal activity and ROS production in patients on HD [16-18].  The 
elucidation of mechanisms focusing on intracellular signaling underlying the impaired 
immune response in neutrophils of HD patients are required to establish therapeutic 
strategies to combat bacterial infections. 
 
Mitogen-activated protein kinases (MAPKs) are major intracellular signal transduction 
factors, through which signals from environmental stimuli are transmitted to the nucleus 
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[19].  Thus far, at least three distinct groups of MAPKs have been identified; 
extracellular signal-regulated kinase (ERK), p38MAPK and c-Jun NH2-terminal kinase 
(JNK).  MAPKs are phosphorylated in response to various stimuli such as growth 
factors, oxidative stresses and inflammatory cytokines [20-21].  Then, phosphorylated 
MAPKs contribute to the activation of nuclear transcription factors regulating the gene 
expression of various molecules.  Thus far, it has been reported that exposure to viable 
S. aureus led to the activation of ERK and p38MAPK in neutrophils from healthy 
volunteers [22, 36], suggesting that these intracellular signaling pathways are involved 
in bacterial clearance by neutrophils. 
 
These findings prompted us to examine the comprehensive analysis focusing on 
intracellular signaling pathways using neutrophils from HD patients to explore the 
mechanisms of susceptibility of HD patients to bacterial infections.  This study showed 
that p38MAPK signaling was impaired in neutrophils isolated from HD patients, which 
were associated with lower killing activity of neutrophils against S. aureus through the 






















Material and Methods 
 
Patients and control subjects 
First, RNA microarray analysis was performed to evaluate the genes related to 
intracellular signaling in whole blood.  For this analysis, 12 patients were enrolled, 
which were 4 HD patients (HD group) and sex- and age-matched 8 hypertensive 
patients without renal dysfunction (eGFR>60ml/min; control group).  The patient 
characteristics are summarized in Table 1.  The numbers of white blood cells and 
neutrophils were not different between both groups. Next, neutrophil functions were 
analyzed in separate groups including 7 HD patients (HD group) and sex- and 
age-matched 10 healthy volunteers (control group).  The patient characteristics are 
summarized in Table 2.  The number of white blood cells was not different between 
both groups.  Blood samples were collected upon entry to the study after informed 
consent was obtained.  This study was approved by the ethics committee of Kanazawa 
University (IRB approval number 285).  None of patients or healthy volunteers had 
diabetes mellitus, malignant neoplasm and bacterial infection. 
 
Reagents 
RPMI 1640 was from Thermo Fisher Science (Waltham, MA, USA), and 10% human 
serum of type AB were from Takara (Kusatsu, Japan). SB202190 was obtained from 
Sigma-Aldrich (St. Louis, MO, USA).  DMSO as a vehicle of SB202190, LB medium 
and Agar were from Wako (Osaka, Japan).   
 
RNA isolation, microarray hybridization and analysis 
For RNA microarray analysis, RNA was isolated by using PAXgene Blood RNA 
System Kit (PreAnalytiX QIAGEN/BD, Hombrechtikon, Switzerland) as previously 
described [23,24].  In brief, blood specimens (2.5 ml) were collected in PAXgene tubes 
from each patient.  RNA was extracted from whole blood following the manufacturer’s 
protocol.  Total RNA (100 ng) was used for the generation of biotin-labelled cRNA 
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using the Affymetrix Two-Cycle cDNA Synthesis Kit (Affymetrix, Santa Clara, CA).  
The biotin-labelled cRNA was hybridized to Affymetrix HG-U133 Plus2.0 GeneChips 
after fragmentation.  After the chips were washed followed by a staining with 
streptavidin and phycoerythrin, they were scanned by using the GeneChip scanner 3000 
(Affymetrix).  Raw data file formats were generated using the Gene Chip Operating 
Software (Affimetrix).  The gene expression analysis was performed using BRB 
ArrayTools ver 4.41 (NCI, http://linus.nci.nih.gov/BRB-ArrayTools.html).  We 
performed pathway class comparison of Bio Carta database between the HD group and 
the control group.  Only those categories with p value < 0.0001 for LS and KS 
permutation statistical tests were considered as statistically significant. 
 
Neutrophil isolation 
Neutrophils were isolated from heparinized whole blood (10 ml) that was collected 
from HD patients or healthy volunteers.  The blood was layered over a Polymorphprep 
resolving media (Accurate Chemical, Westbury, NY) and spun at 500 x g for 35 min.  
The neutrophil rich fraction was collected, and red blood cells were lysed with BD 
PharmLyse (BD Biosciences, San Jose, CA).  The number of neutrophils was counted 
by Cellometer mini (Nexcelom Bioscience, Lawrence, MA).  The purity and the 
viability of neutrophils were assessed by Giemsa staining (Diff-Qik; Gentaur Europe, 
Brussels, Belgium) and flow cytometry analysis of lactoferrin (Beckman Coulter, Brea, 
CA), respectively.  The purity and the viability of neutrophil preparations was over 
95%.  The neutrophils were washed twice with PBS and then resuspended in RPMI 
1640 supplemented with 10% human serum of type AB without antibiotic-antimycotic 
reagent. 
 
Bacterial killing assay 
Bacterial killing assay was performed as described previously [25].  Briefly, S. aureus 
(strain Smith, kindly provided by Dr. Suda, Kanazawa University, Ishikawa, Japan) was 
grown in LB medium until OD 1.9–2.2 at 600 nm.  After opsonized with 10% human 
serum of type AB for 30 min at 37 ºC in a water bath, the S. aureus and 1×105 
neutrophils were incubated together at 1:1 ratio for 240 min at 37ºC 5% CO2 on 96 
wells plates.  Then, neutrophils were lysed by adding distilled H2O and diluted 
7 
 
aliquots were spread on LB agar plates.  After the incubation overnight at 37℃, we 
counted the number of CFU at each plate and calculated the growth rate of S. aureus as 
the ratio of the number of CFU at 240 min to the number of CFU at baseline. 
 
Western blot 
1×106 neutrophils were co-cultured with either opsonized S. aureus at 1:1 ratio or 
stimulated by 10μM N-Formyl-Met-Leu-Phe (fMLP) for 5min (37℃, 5%  CO2), and 
then immediately they were put on ice.  After the cells were spun down at 3000rpm 4℃ 
for 5min, each pellets were lysed in 100 μl of lysis buffer (10 mM Tris–HCl (pH 7.4), 
1% SDS).  A total of 10 μg proteins were loaded per well and separated on a 7% SDS–
PAGE by electrophoresis and then transfer to a nitrocellulose membrane by using iBlot 
2 Gel Transfer Device (Thermo Fisher Science).  The transferred nitrocellulose 
membranes were probed with anti-p38MAPK antibody (Cell Signaling Technology, 
Danvers, MA, USA) or anti-phosphorylated p38MAPK antibody (Cell Signaling 
Technology) at a concentration of 1:2000.  The secondary goat anti-rabbit antibody 
conjugated with horseradish peroxidase was used at a concentration of 1:5000 (Cell 
Signaling Technology).  The membrane was visualized by chemiluminescence using 
the ECL kit (Amersham Biosciences, Piscataway, NJ).  Phosphorylation rate of 
p38MAPK was assessed from each protein expression level by using ChemiDoc Touch 
Imaging System (Bio-Rad Microscience, Hercules, CA, USA). 
 
Measurements of ROS production and MPO activity 
To examine ROS production and MPO activity in neutrophils, 1×105 neutrophils were 
measured after co-culture with S. aureus for 30min (37℃, 5%  CO2).  ROS production 
was measured by using an Oxi Select Intracellular ROS assay kit (Cell Biolabs, Inc., 
San Diego, CA, USA), which uses the oxidation-sensitive fluorescent probe 
2’,7’-dichlorodihydrofluorescein diacetate (DCFH-DA) rapidly oxidized to highly 
fluorescent 2’, 7’- Dichlorodihydrofluorescein (DCF) by ROS.  MPO activity was 
measured by using Neutrophil Myeloperoxidase Activity Assay Kit (Cayman Chemical 
Company, MI, USA). One unit of MPO is defined as the amount of MPO which 
generates taurine chloramine to consume 1.0 μmol of Trinitrobenzenesulfonic per 
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minute at 25 °C.  Fluorescence intensities were measured by plate reader (Tecan, 
Salzburg, Austria) at 480/530 nm for ROS assay or at 650/530 nm in MPO assay. 
 
Lactate dehydrogenase (LDH) assay 
LDH assay was performed to examine the viability of neutrophils using LDH 




The results are expressed as mean values ±SEM.  One-way analysis of variance 
(ANOVA) by the Bonferroni method or the Student’s t test was used to determine the 
significance of differences between groups in this study.  In all analyses, statistical 






The gene expression profiles of p38MAPK Signaling were preferentially declined 
in hemodialysis group. 
BioCarta pathway analysis revealed that 5 out of 264 investigated gene sets passed the 
P<0.0001 significance threshold in whole blood, such as MAPK Signaling Pathway and 
p38MAPK Signaling Pathway (Figure 1a).  Therefore, the expression levels of genes 
associated with p38MAPK signaling pathway were examined as shown in Figure1b.  
As a result, 43 out of 48 p38MAPK signaling-associated genes were down-regulated 
(Figure 1b).  ERK and JNK signaling pathway did not show any statistical 
significance. 
 
Phosphorylation of p38MAPK was impaired in neutrophils of HD patients as 
compared to healthy subjects with or without bacterial stimuli. 
To confirm the impairment of p38MAPK signaling in neutrophils of HD group, we 
examined the phosphorylation of p38MAPK in neutrophils.  As shown in Figure 2a-b, 
neutrophils of HD group demonstrated the suppression of p38MAPK phosphorylation 
as compared to neutrophils of control group without any stimuli.  Next, we examined 
if bacterial stimulation is capable of inducing p38MAPK activation in neutrophils.  
After co-culture of neutrophils with S. aureus for five minutes, p38MAPK 
phosphorylation of neutrophils was much lower in HD group than in control group 
(Figure 2a-b). The bacterial chemotactic peptide fMLP has been reported to induce the 
phosphorylation of p38MAPK in neutrophils, therefore, it is thought to be able to 
modulate neutrophil functions [26].  As shown in Figure 2a-b, fMLP-induced 
phosphorylation of p38MAPK in neutrophils was also suppressed in HD group as 
compared to control group.  We did not see any difference of neutrophil viability 
between both groups (Figure 2c).  These results suggest that p38MAPK signaling was 
significantly impaired in HD patients-derived neutrophils both at baseline and after 
bacterial stimulation. 
 
The bactericidal activity of neutrophils was suppressed in HD patients. 
Neutrophils are the most abundant leukocytes in humans and essential to the innate 
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immune responses against bacterial invasion [15].  In addition, p38MAPK is known to 
be involved in multiple cellular processes such as cell growth, differentiation and 
cytokine productions [27].  Therefore, we hypothesized that the impairment of 
p38MAPK signaling contributes to the susceptibility of HD patients to bacterial 
infections.  To evaluate the bactericidal activity of neutrophils against S. aureus, we 
performed bacterial killing assay by co-culturing neutrophils with S. aureus.  As 
shown in Figure 3a, the growth rate of S. aureus showed about six-fold increase without 
neutrophils.  However, the co-culture of S. aureus with neutrophils of control group 
inhibited the growth of S. aureus almost completely (130.0±49.6%).  On the other 
hand, the growth rate of S. aureus was increased by 376±201.1% with neutrophils of 
HD group (p<0.05), indicating that the bactericidal activity of neutrophils was 
suppressed in HD group compared to control group.  There was no difference in 
neutrophil viability between both groups at each time point of this assay (Figure 3b). 
 
The levels of ROS production in neutrophils after co-culture with S. aureus were 
lower in HD patients than those in healthy subjects.  
Neutrophils are capable of generating high amount of ROS by nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase following phagocytosis to destroy invading 
bacteria [15].  To investigate whether neutrophil ROS production is dysregulated in 
HD patients resulting in the loss of bactericidal activity, we measured the levels of ROS 
by the stimulation with S. aureus.  Under the control state, the levels of ROS 
production in neutrophils of HD group showed the declining trend as compared those in 
control group, although it was not statistically significant (Figure 4a).  After co-culture 
with S. aureus or fMLP, the levels of ROS production were lower in neutrophils of HD 
group than control group, suggesting the involvement of ROS dysregulation in 
disturbed bactericidal ability of HD group (Figure 4a).  In addition, MPO is a major 
component of neutrophilic granules and released from activated neutrophils, thereby 
playing critical roles in degrading invading pathogen [15].  We hypothesized that MPO 
release was also inhibited in HD group after the stimulation with S. aureus, however, 
there was no difference between both groups in neutrophil MPO activities after 
co-culture with S. aureus (Figure 4b).  These findings suggest that low bactericidal 




The selective pharmacological inhibitor of p38MAPK suppressed the bactericidal 
activity and the levels of ROS production in neutrophils of healthy subjects. 
As the mechanisms of ROS production in neutrophils, p38MAPK signaling has been 
reported to play important roles through the regulation of NADPH oxidase [21].  To 
confirm the involvement of p38MAPK signaling in bactericidal activity in neutrophils, 
we examined the effect of the selective pharmacological p38MAPK inhibitor SB202190 
on neutrophil bactericidal activity as well as ROS production.  First, LDH assay did 
not show any cell toxicity of SB202190 (date not shown).  As shown in Figure 5a, 
bacterial killing assay showed five-fold increase of the growth rate of S. aureus without 
neutrophils whereas co-culture of S. aureus with healthy neutrophils almost totally 
inhibited the growth of S. aureus.  In contrast, treatment with the SB202190 
significantly suppressed bacterial killing function of healthy neutrophils in a dose 
dependent manner (Figure 5a).  In addition, we investigated the effect of the 
p38MAPK signaling on the production of ROS as an anti-bacterial mediator.  In the 
healthy neutrophils, ROS production was induced by a co-culture with S. aureus, 





In this study, we found that p38MAPK signaling pathway was impaired in whole blood, 
especially in neutrophils of HD patients.  Comprehensive analyses of intracellular 
signalings in neutrophils using microarray system showed the down-regulation of 
p38MAPK signaling-related genes, and phosphorylation of p38MAPK was also 
suppressed in HD patients under control state in western blotting.  The extent of 
p38MAPK phosphorylation by co-culturing neutrophils with S. aureus was also lower 
in HD patients than in healthy subjects.  Bacterial killing assay to examine the 
neutrophil bactericidal activity showed that S. aureus growth rate was higher in HD 
patients than that in healthy subjects.  In addition, the levels of ROS from neutrophils 
after co-culture with S. aureus were lower in HD patients than those in healthy subjects, 
suggesting that neutrophil bactericidal function was dysregulated in HD patients 
through the impairment of ROS production.  Furthermore, the treatment with 
p38MAPK inhibitor suppressed bactericidal function as well as ROS production in 
neutrophils.  From these findings, we conclude that the impaired p38MAPK signaling 
pathway might contribute to the suppression of neutrophil bactericidal activity in HD 
patients through the dysregulation of ROS production.  
 
Neutrophils have been well-known to play essential roles for acute inflammation.  
Neutrophils are recruited to the sites of acute bacterial infection, and significantly 
contribute to the elimination of pathogens through various anti-bacterial functions.  
Typically, neutrophils phagocyte pathogens, and encapsulate them in phagosomes.  
Then, neutrophils kill encapsulated pathogens using NADPH oxygenase-dependent 
ROS production or release of antibacterial proteins such as MPO from granules [28].    
In this study, neutrophils of HD patients failed to effectively kill S. aureus, and showed 
lower activation of p38MAPK signaling as well as less production of ROS as compared 
to neutrophils of healthy subjects.  Pharmacological inhibition of p38MAPK 
significantly suppressed bacterial killing and ROS production even in healthy 
neutrophils.  In contrast, the release of MPO by co-culture of neutrophils with S. 
aureus showed no difference in both group.  These findings suggest that 
p38MAPK-ROS system is disturbed in neutrophils of HD patients, thereby reducing 
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bacterial killing activity in neutrophils.  Previous study reported that neutrophil 
phagocytosis of S. aureus was not affected by p38MAPK inhibition [29], suggesting 
that phagocytosis may not be a major factor for p38MAPK-dependent bacterial killing.  
In addition, prior studies reported phagocytosis of neutrophils is not impaired by uremia 
[30, 31].  Further investigations will be required to clarify the role of phagocytosis in 
neutrophils of HD patients. 
 
Clarifying the mechanisms through which neutrophils activate p38MAPK signaling 
leading to the clearance of S. aureus is important to discover therapeutic targets.  
Neutrophils are known to be activated by a diverse repertoire of receptors such as 
integrins, Fc-receptors, chemokine receptors and Toll-like receptors [15].  Among 
them, β2-integrin (C11/CD18) has been reported to be critical in mediating neutrophil 
activation for host defense responses to bacterial infection [32].  CD18 deficiency in 
human causes leukocyte adhesion deficiency type I syndrome, in which these patients 
present early in life with repeated bacterial infections [33].  These phenotypes have 
also been reported to be recapitulated in CD18-deficient mice [34, 35].  As the 
signaling pathway downstream of β2-integrin in neutrophils after engagement with 
S.aureus, spleen tyrosine kinase (Syk) has been reported to be a critical component [36, 
37].  Syk-deficient neutrophils showed poor activation of the NADPH oxidase in 
response to S aureus through the impaired activation of p38MAPK.  In addition, loss 
of Syk specifically in neutrophils was reported to result in reduced clearance of S. 
aureus after subcutaneous or intraperitoneal infection [38].  Based on these findings 
and the data we found in this study, it may be possible to speculate that β2-integrin 
activation could be impaired in neutrophils of HD patients.  Previous study in healthy 
dogs showed that the expression levels of CD11/CD18 on neutrophils was not changed 
by hemodialysis procedure itself [39].  Further studies will be needed to elucidate the 
precise mechanisms by which p38MAPK activation is impaired in neutrophils of HD 
patients. 
 
Besides the roles of p38MAPK in host defense systems against bacterial infections, 
p38MAPK signaling has been linked to various inflammatory diseases including 
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rheumatoid arthritis, atherosclerosis, glomerulonephritis and diabetes [40-44].  
p38MAPK signaling regulates the production of inflammatory cytokines and 
chemokines through the activation of transcriptional factors such as nuclear factor 
(NF)-kB, which in turn contributes to the signaling of inflammatory molecules via their 
receptors, thereby being recognized to be responsible for the vicious cycle of 
inflammations [45].  Therefore, p38MAPK has been extensively investigated to 
develop anti-inflammatory drugs in many inflammatory diseases [46-48].  However, 
recent study has shown that sepsis patients displayed a reduced capacity to activate 
NF-kB in inflammatory cells, suggesting that Sepsis-induced immunosuppression 
associates with a defect in the capacity to activate NF-kB [49].  In addition, mice 
lacking MAPK-activated protein kinase 2, which is a substrate of p38MAPK, showed 
diminished resistance to L. monocytogenes due to impaired control of bacterial growth 
[50].  From these findings and our data in this study suggest that p38MAPK inhibition 
should be done in appropriate time and place. 
 
In summary, we have shown that p38MAPK signaling was impaired in neutrophils 
isolated from HD patients, thereby contributing to the lower killing activity of 
neutrophils against S. aureus through the less production of ROS.  Given the 
fundamental involvement of these processes in the clearance of pathogens, our results 
suggest that p38MAPK signaling may be one of therapeutic targets for 
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Legends to figures 
Figure 1. The gene expression profiles of p38MAPK Signaling were preferentially 
declined in hemodialysis (HD) group.  (a) BioCarta pathway analysis (HD group; n = 
4, control group; n = 8) by BRB-ArrayTools.  5 out of 264 investigated gene sets 
passed the p < 0.0001 vs controls.  (b) The expression levels of genes associated with 
p38MAPK signaling pathway.  The 43 out of 48 p38MAPK signaling-associated genes 
were down-regulated in HD group.  MAPK; mitogen-activated protein kinase, EGF; 
epidermal growth factor, GPCRs; G protein-coupled receptors, ADP; adenosine 
diphosphate. 
 
Figure 2. Phosphorylation of p38MAPK was suppressed in neutrophils of HD 
patients as compared to healthy subjects with or without bacterial stimuli.  (a-b) 
The phosphorylation of p38MAPK in neutrophils by the stimulation with opsonized S. 
aureus or 10μM fMLP for 5 min.  Quantification was performed with ChemiDoc 
Touch Imaging System and the data are expressed as mean intensities of phosphorylated 
p38MAPK bands relative to intensities of total p38MAPK bands ± SEM (n = 6/each 
group).  (c) Neutrophil viability at each time point of this assay.  Data are expressed 
as mean + SEM (n = 6/each group).  *p < 0.05.  **p < 0.05 vs. control neutrophils at 
0 min.  #p < 0.05 vs. HD neutrophils at 0 min.  NS; not significant. 
 
Figure 3. The bactericidal activity of neutrophils was suppressed in HD patients as 
compared to healthy subjects.  (a) The growth rates of S. aureus after the co-culture 
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with neutrophils from HD patients or controls.  The growth rates of S. aureus were 
expressed as the ratio of the number of CFU at 240 min to the number of CFU at 
baseline + SEM (n = 7/HD group and n = 10/control group).  (b) Neutrophil viability 
at each time point of this assay (n = 6/each group).  Data are expressed as mean + SEM.  
*p < 0.05.  NS; not significant. 
 
Figure 4. The levels of ROS production in neutrophils after co-culture with S. 
aureus or fMLP were lower in HD patients than those in healthy subjects.  (a) The 
levels of ROS production in neutrophils after the co-culture with S. aureus or fMLP for 
30 min.  Data are expressed mean + SEM (n = 5/each group).  (b) MPO activity in 
neutrophils after the co-culture with S. aureus for 30 min.  Data are expressed mean + 
SEM (n = 5/each group).  †p < 0.05 vs. unstimulated control neutrophils.  *p < 0.05.  
NS; not significant. 
 
Figure 5. The selective pharmacological inhibitor of p38MAPK suppressed the 
bactericidal activity and the levels of ROS production in neutrophils of healthy 
subjects.  (a) The effect of p38MAPK inhibition on the growth rates of S. aureus after 
the co-culture with neutrophils from healthy subjects.  The growth rates of S. aureus 
were expressed as the ratio of the number of CFU at 240 min to the number of CFU at 
baseline + SEM (n = 6/each group).  (b) The levels of ROS production in neutrophils 
after the co-culture with S. aureus with or without p38MAPK inhibition.  Data are 
expressed mean + SEM (n = 6/each group).  *p < 0.05. 
 
